Billionaire philanthropist Bill Gates has donated $30 million towards incentivising the development of an Alzheimer’s diagnostic test.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, new findings suggest.
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumour suppressor.
Melanoma is it’s treatable if caught early enough. And a new blood test might be able to help with faster and easier diagnosis. Here’s what has to happen for the test to reach clinics:
Scientists have discovered that CRISPR/Cas9 gene editing can cause greater genetic damage in cells than was previously thought.
Natural selection shapes genomes to evolve and to adapt but, are the rules of natural selection also applying to cancer genome evolution? Researchers suggest negative selection acting on cancer-essential genes plays a more important role than previously anticipated.
Scientists have published one of the most detailed maps ever made of structural variations in a cancer cell’s genome.
A new method makes it possible to systematically identify specialised proteins that unpack DNA inside the nucleus of a cell, making the usually dense DNA more accessible for gene expression and other functions.
Dr. Mark McClellan joined Johnson & Johnson’s board of directors after leaving the FDA, but the connection often isn’t mentioned in research papers or public events.